Kristensen Anne F, Kristensen Søren R, Falkmer Ursula, Münster Anna-Marie B, Pedersen Shona
a Department of Clinical Biochemistry , Aalborg University Hospital , Aalborg , Denmark.
b Department of Clinical Medicine , Aalborg University , Aalborg , Denmark.
Scand J Clin Lab Invest. 2018 May;78(3):175-179. doi: 10.1080/00365513.2018.1427280. Epub 2018 Jan 16.
The Calibrated Automated Thrombography (CAT) is an in vitro thrombin generation (TG) assay that holds promise as a valuable tool within clinical diagnostics. However, the technique has a considerable analytical variation, and we therefore, investigated the analytical and between-subject variation of CAT systematically. Moreover, we assess the application of an internal standard for normalization to diminish variation.
20 healthy volunteers donated one blood sample which was subsequently centrifuged, aliquoted and stored at -80 °C prior to analysis. The analytical variation was determined on eight runs, where plasma from the same seven volunteers was processed in triplicates, and for the between-subject variation, TG analysis was performed on plasma from all 20 volunteers. The trigger reagents used for the TG assays included both PPP reagent containing 5 pM tissue factor (TF) and PPPlow with 1 pM TF. Plasma, drawn from a single donor, was applied to all plates as an internal standard for each TG analysis, which subsequently was used for normalization.
The total analytical variation for TG analysis performed with PPPlow reagent is 3-14% and 9-13% for PPP reagent. This variation can be minimally reduced by using an internal standard but mainly for ETP (endogenous thrombin potential). The between-subject variation is higher when using PPPlow than PPP and this variation is considerable higher than the analytical variation.
TG has a rather high inherent analytical variation but considerable lower than the between-subject variation when using PPPlow as reagent.
校准自动血栓形成测定法(CAT)是一种体外凝血酶生成(TG)测定法,有望成为临床诊断中有价值的工具。然而,该技术存在相当大的分析变异,因此,我们系统地研究了CAT的分析变异和个体间变异。此外,我们评估了使用内标进行标准化以减少变异的应用。
20名健康志愿者捐献一份血样,随后进行离心、分装,并在分析前储存在-80°C。在八次检测中测定分析变异,其中来自相同7名志愿者的血浆进行三次重复处理,对于个体间变异,对所有20名志愿者的血浆进行TG分析。用于TG测定的触发试剂包括含有5 pM组织因子(TF)的PPP试剂和含有1 pM TF的PPPlow。从单一供体采集的血浆作为每次TG分析的内标应用于所有平板,随后用于标准化。
使用PPPlow试剂进行TG分析的总分析变异为3%-14%,使用PPP试剂时为9%-13%。使用内标可将这种变异最小化,但主要是针对ETP(内源性凝血酶潜力)。使用PPPlow时个体间变异高于使用PPP时,且这种变异显著高于分析变异。
TG具有相当高的固有分析变异,但当使用PPPlow作为试剂时,其变异显著低于个体间变异。